Xylem (NYSE:XYL) will release its quarterly earnings report on Tuesday, 2026-02-10. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Xylem to report an earnings per share (EPS) of $1.41.

The market awaits Xylem's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Earnings Track Record

The company's EPS beat by $0.13 in the last quarter, leading to a 1.63% increase in the share price on the following day.

Here's a look at Xylem's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	1.24	1.14	0.95	1.13
EPS Actual	1.37	1.26	1.03	1.18
Price Change %	2.00	-2.00	2.00	0.00

Performance of Xylem Shares

Shares of Xylem were trading at $142.12 as of February 06. Over the last 52-week period, shares are up 7.66%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analyst Insights on Xylem

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Xylem.

Xylem has received a total of 3 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $150.33, the consensus suggests a potential 5.78% upside.

Peer Ratings Overview

In this comparison, we explore the analyst ratings and average 1-year price targets of Dover, Ingersoll Rand and Fortive, three prominent industry players, offering insights into their relative performance expectations and market positioning.

• Analysts currently favor an Neutral trajectory for Dover, with an average 1-year price target of $221.5, suggesting a potential 55.85% upside.
• Analysts currently favor an Buy trajectory for Ingersoll Rand, with an average 1-year price target of $90.4, suggesting a potential 36.39% downside.
• Analysts currently favor an Neutral trajectory for Fortive, with an average 1-year price target of $60.38, suggesting a potential 57.51% downside.

Comprehensive Peer Analysis Summary

Within the peer analysis summary, vital metrics for Dover, Ingersoll Rand and Fortive are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

Company	Consensus	Revenue Growth	Gross Profit	Return on Equity
Xylem	Neutral	7.79%	$883M	2.04%
Dover	Neutral	1.02%	$833.59M	3.74%
Ingersoll Rand	Buy	5.05%	$855.20M	2.42%
Fortive	Neutral	9.29%	$649.20M	2.87%

Key Takeaway:

Xylem ranks highest in revenue growth among its peers. It has the highest gross profit and is in the middle for return on equity.

Get to Know Xylem Better

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.

Financial Insights: Xylem

Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.

Positive Revenue Trend: Examining Xylem's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.79% as of 30 September, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 10.01%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.04%, the company may need to address challenges in generating satisfactory returns for shareholders.

Return on Assets (ROA): Xylem's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.32%, the company may face hurdles in generating optimal returns from its assets.

Debt Management: Xylem's debt-to-equity ratio is below the industry average. With a ratio of 0.19, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

To track all earnings releases for Xylem visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.